Home
Healthcare
Healthcare & Pharmaceuticals
Skin Substitutes Market Size, Share & Trends Growth [2031]

Skin Substitutes Market

Name: Growth Market Reports
Address: 500 East E Street, Ontario, 91764, USA
Telephone: +1 909 414 1393

Segments - by Type (Acellular, Cellular Allogeneic, Cellular autologous, Xenograft, and Others), Origin (Human Dermis, Porcine Dermis, and Bovine Dermis), Application (Acute Wounds and Chronic Wound), End-user (Hospitals, Ambulatory Surgical Centers, and Clinics) and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends and, Forecast 2023 – 2031

HC-5650
4.8 Rating
330 Pages

10-09-2023
68 Reviews

Author :

Raksha Sharma

Fact-checked by :

Vineet Pandey

Editor :

Vishal Golekar

Report Description

Market Outlook:

The Global Skin Substitutes Market was estimated at USD 1,781.7 Million in 2022 and is anticipated to reach USD ~ 5,426.0 Million by 2031, expanding at a CAGR of 13.6% during the forecast period.

Skin substitutes, also known as artificial or synthetic skin, are medical products that are designed to replace damaged or missing skin tissue. They are typically used in the treatment of severe burns, chronic wounds, and skin defects resulting from injury or surgery. Skin substitutes are engineered to promote wound healing, reduce pain, and improve the appearance and function of the skin. These substitutes are made from various materials, including synthetic polymers, biological tissues, or a combination of both, and they serve as a temporary or permanent replacement for natural skin until the patient’s skin regenerates or heals.

Macro-economic Factors

Healthcare Expenditure

Healthcare expenditure is a crucial macroeconomic factor that significantly influences the global skin substitutes market. High healthcare expenditure generally leads to increased access to healthcare services. This includes wound care and treatment options, such as skin substitutes. Countries or regions allocate a large amount of funds to healthcare, which drives the demand for advanced wound care products. Healthcare expenditure affects the affordability of skin substitutes for patients. Patients have access to better insurance coverage or government subsidies in regions with robust healthcare spending, making skin substitutes affordable. High healthcare expenditure leads to better healthcare infrastructure, including wound care facilities and specialized centres. This infrastructure supports the adoption of skin substitutes.

Economic Growth and Stability

Economic growth and stability influence various aspects of consumer spending on healthcare products and treatments, ultimately affecting the demand for skin substitutes. Economic growth is often correlated with increased investment in research and development, including wound care treatment and grafting. Stable and growing economies tend to allocate increasing resources to healthcare and product innovation, leading to large number of treatments.

Economic stability results in the high demand for innovative treatments and therapies. Populations have high disposable incomes and improved access to healthcare, as economies grow, fostering interest in cutting-edge treatments. This, in turn, leads to a rise in wound care treatments and the need for skin substitutes.

Skin Substitues Market Dynamics

Market Driver- Rising Chronic Wounds

Increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, due to factors such as aging populations and high rates of diabetes, is boosting the demand for skin substitutes. Chronic wounds represent a silent epidemic that affects a significant portion of the global population. Several factors contribute to the surge in chronic wounds, including the aging population, steep rise in the prevalence of obesity that is heavily correlated to diabetes, and the late effects of radiation therapies. According to a research article published by Mary Ann Liebert, Inc., in March 2021, around 2% of the population in the US was affected by chronic wounds.

Additionally, 3% of the population aged over 65 years suffer from open wounds. Moreover, the government of the US estimates the elderly population to continue to rise above 77 million by 2060, indicating that chronic wounds such as pressure ulcers continue to be an increasingly common problem among the elderly population by then.

Market Driver- Technological Advancements

Technological advancements play a pivotal role in driving the skin substitute market by continually improving the quality, effectiveness, and accessibility of skin substitute products. Ongoing research in materials science has led to the creation of innovative biomaterials and scaffolds that closely mimic human skin. These materials provide support for cell growth and tissue regeneration. Technological advancements in bioprinting and 3D tissue engineering have allowed for the precise fabrication of skin substitutes with complex structures, improving their functionality and appearance.

Moreover, stem cell research and tissue engineering techniques have enabled the production of skin substitutes containing live cells, which actively contribute to wound healing and tissue regeneration. Technological advancements benefit patients and drive the skin substitutes market by expanding its applications and improving treatment outcomes.

Market Restraint- Regulatory Approvals

Regulatory approvals pose a significant restraint for the global skin substitutes market. Regulatory agencies often impose strict requirements for the approval of skin substitutes to ensure patient safety and product efficacy. Meeting these requirements is time-consuming and expensive for manufacturers. The regulatory approval process is lengthy, involving multiple phases of testing and clinical trials. This delays the time taken for a product to reach the market, impacting its availability to patients in need.

Complying with regulatory requirements, conducting clinical trials, and gathering the necessary data result in high development costs. This makes it challenging for small companies to enter the market. Moreover, barriers to entry are high, due to the rigorous regulatory hurdles, thereby reducing competition and potentially limiting innovation in the market.

Market Opportunity- Improving Healthcare Infrastructure

Improved healthcare infrastructure leads to increased awareness and access to advanced medical treatments, including skin substitutes. This results in high adoption rates and a large patient pool. Improved infrastructure facilitates the efficient distribution of skin substitutes to healthcare facilities, ensuring timely access for patients in need. Moreover, improving healthcare infrastructure in the highly populous countries in APAC, such as China, India, and Japan, is providing potential market opportunities and attracting stakeholders to expand their portfolios in the skin substitutes market in the region.

For instance, in March 2019, AVITA Medical collaborated with COSMOTEC, a division of M3 Group Company, to market and distribute skin substitute products in Japan. The collaboration is expected to offer AVITA Medical significant opportunities, considering the recent surge in the number of patients in Japan suffering from decubitus ulcers and chronic wounds.

Scope of the Skin Substitutes Market Report

The report on the Global Skin Substitutes Market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Skin Substitutes Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Type (Acellular, Cellular Allogeneic, Cellular autologous, Xenograft, and Others), Origin (Human Dermis, Porcine Dermis, and Bovine Dermis), Application (Acute Wounds and Chronic Wound), End-user (Hospitals, Ambulatory Surgical Centers, and Clinics)
Regional Scope	Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered	Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Organogenesis Holdings Inc, Tissue Regenix Group plc, MIMEDX Group, Inc, Mallinckrodt plc, HansBiomed Corp., Reprise Biomedical Inc., Bioventus Inc., PolyNovo Limited, BioHorizons, Harbor MedTech, Inc., Regenity, and Smith+Nephew.

Skin Substitutes Market Segmental Outlook

Based on Type, the market is segmented into Acellular, Cellular Allogeneic, Cellular autologous, Xenograft, and Others. The Acellular segment is expected to hold a considerable share of the market during the forecast, as acellular allografts are easy to use and have no immunologic response; however, the processing time and possibility of graft rejection and infection are some disadvantages of this skin substitute.

On the basis of origin, the market is fragmented into human dermis, porcine dermis, and bovine dermis. The human dermis segment holds a key share of the market during the forecasted period. A wide array of skin substitutes is available in the market for the treatment of burn injury, due to the advent and progress of biotechnology and tissue engineering. For instance, Dermagraft is a product manufactured from human neonatal foreskin fibroblasts, which are seeded in a matrix of bioabsorbable polyglactin.

On the basis of application, the market is bifurcated into acute wounds and chronic wound. The chronic wound segment holds a key share of the market during the forecasted period. Increasing prevalence of diabetes across the globe is one of the major causes of diabetic foot ulcers.

For instance, according to the American Diabetes Association, in 2019, 37.3 million Americans, or 11.3% of the population, had diabetes.

On the basis of end-user, the market is divided into hospitals, ambulatory surgical centers, and clinics. The hospitals segment holds a key share of the market during the forecasted period, owing to the increasing number of medical and surgical procedures across the globe. Hospitals are the primary settings where surgical procedures take place.

Regional Outlook

Based on regions, the market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a significant share of the market in 2022, owing to the growing incidence of chronic wounds. Additionally, presence of highly developed healthcare infrastructure and increasing awareness about wound management among the population are driving the market in the region.

Key Benefits for Industry Participants & Stakeholders

In-depth Analysis of the Global Skin Substitutes Market
Historical, Current, and Projected Market Size in Terms of Value
Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
Industry Drivers, Restraints, and Opportunities Covered in the Study
Recent Industry Trends and Developments
Competitive Landscape & Strategies of Key Players
Neutral Perspective on Global Skin Substitutes Market PerProduct Typeance

Segments

By Type

Acellular
Cellular Allogeneic
Cellular autologous
Xenograft
Others

By Origin

Human Dermis
Porcine Dermis
Bovine Dermis

By Application

Acute Wounds
Chronic Wound

By End-user

Hospitals
Ambulatory Surgical Centers
Clinics

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Key Market Players Profiled in the Report

Mölnlycke Health Care AB
Integra LifeSciences Holdings Corporation
Organogenesis Holdings Inc
Tissue Regenix Group plc
MIMEDX Group, Inc
Mallinckrodt plc
HansBiomed Corp.
Reprise Biomedical Inc.
Bioventus Inc.
PolyNovo Limited
BioHorizons
Harbor MedTech, Inc.
Regenity
Smith+Nephew

Competitive Landscape

Manufacturers operating in the Global Skin Substitutes Market are Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Organogenesis Holdings Inc, Tissue Regenix Group plc, MIMEDX Group, Inc, Mallinckrodt plc, HansBiomed Corp., Reprise Biomedical Inc., Bioventus Inc., PolyNovo Limited, BioHorizons, Harbor MedTech, Inc., Regenity, and Smith+Nephew.
Market players are pursuing strategies such as acquisitions, product launches, collaborations, and geographic expansion to leverage untapped opportunities in the Global Skin Substitutes Market.

Table Of Content

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Skin Substitutes Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Skin Substitutes Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Skin Substitutes Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Skin Substitutes Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Skin Substitutes Market Size & Forecast, 2016-2031
      4.5.1 Skin Substitutes Market Size and Y-o-Y Growth
      4.5.2 Skin Substitutes Market Absolute $ Opportunity
   4.6 4.6 Current & Emerging Trends
   4.7 Technology Trend Analysis
   4.8 Market Entry Strategy
   4.9 Market Investments Scenario
   4.10 3D Bioprinting of Functional Skin Substitutes: Overview
   4.11 Development of New Biomaterials to be Applied as Skin Substitutes: Overview
   4.12 Skin Substitutes for the Management of Mohs Micrographic Surgery Wounds: Review
Chapter 5 Global Skin Substitutes Market Analysis and Forecast By Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Type
      5.1.2 Basis Point Share (BPS) Analysis By Type
      5.1.3 Absolute $ Opportunity Assessment By Type
   5.2 Skin Substitutes Market Size Forecast By Type
      5.2.1 Acellular
      5.2.2 Cellular Allogeneic
      5.2.3 Cellular Autologous
      5.2.4 Xenograft
      5.2.5 Others
   5.3 Market Attractiveness Analysis By Type
Chapter 6 Global Skin Substitutes Market Analysis and Forecast By Origin
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Origin
      6.1.2 Basis Point Share (BPS) Analysis By Origin
      6.1.3 Absolute $ Opportunity Assessment By Origin
   6.2 Skin Substitutes Market Size Forecast By Origin
      6.2.1 Human Dermis
      6.2.2 Porcine Dermis
      6.2.3 Bovine Dermis
   6.3 Market Attractiveness Analysis By Origin
Chapter 7 Global Skin Substitutes Market Analysis and Forecast By Application
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By Application
      7.1.2 Basis Point Share (BPS) Analysis By Application
      7.1.3 Absolute $ Opportunity Assessment By Application
   7.2 Skin Substitutes Market Size Forecast By Application
      7.2.1 Acute Wounds
         7.2.1.1 Burns
         7.2.1.2 Trauma
         7.2.1.3 Others
      7.2.2 Chronic Wound
         7.2.2.1 Diabetic Foot Ulcers
         7.2.2.2 Venous Leg Ulcers
         7.2.2.3 Pressure Ulcer
         7.2.2.4 Skin Cancer (Mohs Surgery)
         7.2.2.5 Others
   7.3 Market Attractiveness Analysis By Application
Chapter 8 Global Skin Substitutes Market Analysis and Forecast By End-user
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities By End-user
      8.1.2 Basis Point Share (BPS) Analysis By End-user
      8.1.3 Absolute $ Opportunity Assessment By End-user
   8.2 Skin Substitutes Market Size Forecast By End-user
      8.2.1 Hospitals
      8.2.2 Ambulatory Surgical Centers
      8.2.3 Clinics
   8.3 Market Attractiveness Analysis By End-user
Chapter 9 Global Skin Substitutes Market Analysis and Forecast by Region
   9.1 Introduction
      9.1.1 Key Market Trends & Growth Opportunities by Region
      9.1.2 Basis Point Share (BPS) Analysis by Region
      9.1.3 Absolute $ Opportunity Assessment by Region
   9.2 Skin Substitutes Market Size Forecast by Region
      9.2.1 North America
      9.2.2 Europe
      9.2.3 Asia Pacific
      9.2.4 Latin America
      9.2.5 Middle East & Africa (MEA)
   9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
   10.1 Introduction
   10.2 Current & Future Impact Analysis
   10.3 Economic Impact Analysis
   10.4 Government Policies
   10.5 Investment Scenario
Chapter 11 North America Skin Substitutes Analysis and Forecast
   11.1 Introduction
   11.2 North America Skin Substitutes Market Size Forecast by Country
      11.2.1 U.S.
      11.2.2 Canada
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 North America Skin Substitutes Market Size Forecast By Type
      11.6.1 Acellular
      11.6.2 Cellular Allogeneic
      11.6.3 Cellular Autologous
      11.6.4 Xenograft
      11.6.5 Others
   11.7 Basis Point Share (BPS) Analysis By Type
   11.8 Absolute $ Opportunity Assessment By Type
   11.9 Market Attractiveness Analysis By Type
   11.10 North America Skin Substitutes Market Size Forecast By Origin
      11.10.1 Human Dermis
      11.10.2 Porcine Dermis
      11.10.3 Bovine Dermis
   11.11 Basis Point Share (BPS) Analysis By Origin
   11.12 Absolute $ Opportunity Assessment By Origin
   11.13 Market Attractiveness Analysis By Origin
   11.14 North America Skin Substitutes Market Size Forecast By Application
      11.14.1 Acute Wounds
         11.14.1.1 Burns
         11.14.1.2 Trauma
         11.14.1.3 Others
      11.14.2 Chronic Wound
         11.14.2.1 Diabetic Foot Ulcers
         11.14.2.2 Venous Leg Ulcers
         11.14.2.3 Pressure Ulcer
         11.14.2.4 Skin Cancer (Mohs Surgery)
         11.14.2.5 Others
   11.15 Basis Point Share (BPS) Analysis By Application
   11.16 Absolute $ Opportunity Assessment By Application
   11.17 Market Attractiveness Analysis By Application
   11.18 North America Skin Substitutes Market Size Forecast By End-user
      11.18.1 Hospitals
     11.18.2 Ambulatory Surgical Centers
      11.18.3 Clinics
   11.19 Basis Point Share (BPS) Analysis By End-user
   11.20 Absolute $ Opportunity Assessment By End-user
   11.21 Market Attractiveness Analysis By End-user
Chapter 12 Europe Skin Substitutes Analysis and Forecast
   12.1 Introduction
   12.2 Europe Skin Substitutes Market Size Forecast by Country
      12.2.1 Germany
      12.2.2 France
      12.2.3 Italy
      12.2.4 U.K.
      12.2.5 Spain
      12.2.6 Russia
      12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Europe Skin Substitutes Market Size Forecast By Type
      12.6.1 Acellular
      12.6.2 Cellular Allogeneic
      12.6.3 Cellular Autologous
      12.6.4 Xenograft
      12.6.5 Others
   12.7 Basis Point Share (BPS) Analysis By Type
   12.8 Absolute $ Opportunity Assessment By Type
   12.9 Market Attractiveness Analysis By Type
   12.10 Europe Skin Substitutes Market Size Forecast By Origin
      12.10.1 Human Dermis
      12.10.2 Porcine Dermis
      12.10.3 Bovine Dermis
   12.11 Basis Point Share (BPS) Analysis By Origin
   12.12 Absolute $ Opportunity Assessment By Origin
   12.13 Market Attractiveness Analysis By Origin
   12.14 Europe Skin Substitutes Market Size Forecast By Application
      12.14.1 Acute Wounds
         12.14.1.1 Burns
         12.14.1.2 Trauma
         12.14.1.3 Others
      12.14.2 Chronic Wound
         12.14.2.1 Diabetic Foot Ulcers
         12.14.2.2 Venous Leg Ulcers
         12.14.2.3 Pressure Ulcer
         12.14.2.4 Skin Cancer (Mohs Surgery)
         12.14.2.5 Others
   12.15 Basis Point Share (BPS) Analysis By Application
   12.16 Absolute $ Opportunity Assessment By Application
   12.17 Market Attractiveness Analysis By Application
   12.18 Europe Skin Substitutes Market Size Forecast By End-user
      12.18.1 Hospitals
      12.18.2 Ambulatory Surgical Centers
      12.18.3 Clinics
   12.19 Basis Point Share (BPS) Analysis By End-user
   12.20 Absolute $ Opportunity Assessment By End-user
   12.21 Market Attractiveness Analysis By End-user
Chapter 13 Asia Pacific Skin Substitutes Analysis and Forecast
   13.1 Introduction
   13.2 Asia Pacific Skin Substitutes Market Size Forecast by Country
      13.2.1 China
      13.2.2 Japan
      13.2.3 South Korea
      13.2.4 India
      13.2.5 Australia
      13.2.6 South East Asia (SEA)
      13.2.7 Rest of Asia Pacific (APAC)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Asia Pacific Skin Substitutes Market Size Forecast By Type
      13.6.1 Acellular
      13.6.2 Cellular Allogeneic
      13.6.3 Cellular Autologous
      13.6.4 Xenograft
      13.6.5 Others
   13.7 Basis Point Share (BPS) Analysis By Type
   13.8 Absolute $ Opportunity Assessment By Type
   13.9 Market Attractiveness Analysis By Type
   13.10 Asia Pacific Skin Substitutes Market Size Forecast By Origin
      13.10.1 Human Dermis
      13.10.2 Porcine Dermis
      13.10.3 Bovine Dermis
   13.11 Basis Point Share (BPS) Analysis By Origin
   13.12 Absolute $ Opportunity Assessment By Origin
   13.13 Market Attractiveness Analysis By Origin
   13.14 Asia Pacific Skin Substitutes Market Size Forecast By Application
      13.14.1 Acute Wounds
         13.14.1.1 Burns
         13.14.1.2 Trauma
         13.14.1.3 Others
      13.14.2 Chronic Wound
         13.14.2.1 Diabetic Foot Ulcers
         13.14.2.2 Venous Leg Ulcers
         13.14.2.3 Pressure Ulcer
         13.14.2.4 Skin Cancer (Mohs Surgery)
         13.14.2.5 Others
   13.15 Basis Point Share (BPS) Analysis By Application
   13.16 Absolute $ Opportunity Assessment By Application
   13.17 Market Attractiveness Analysis By Application
   13.18 Asia Pacific Skin Substitutes Market Size Forecast By End-user
      13.18.1 Hospitals
      13.18.2 Ambulatory Surgical Centers
      13.18.3 Clinics
   13.19 Basis Point Share (BPS) Analysis By End-user
   13.20 Absolute $ Opportunity Assessment By End-user
   13.21 Market Attractiveness Analysis By End-user
Chapter 14 Latin America Skin Substitutes Analysis and Forecast
   14.1 Introduction
   14.2 Latin America Skin Substitutes Market Size Forecast by Country
      14.2.1 Brazil
      14.2.2 Mexico
      14.2.3 Rest of Latin America (LATAM)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Latin America Skin Substitutes Market Size Forecast By Type
      14.6.1 Acellular
      14.6.2 Cellular Allogeneic
      14.6.3 Cellular Autologous
      14.6.4 Xenograft
      14.6.5 Others
   14.7 Basis Point Share (BPS) Analysis By Type
   14.8 Absolute $ Opportunity Assessment By Type
   14.9 Market Attractiveness Analysis By Type
   14.10 Latin America Skin Substitutes Market Size Forecast By Origin
      14.10.1 Human Dermis
      14.10.2 Porcine Dermis
      14.10.3 Bovine Dermis
   14.11 Basis Point Share (BPS) Analysis By Origin
   14.12 Absolute $ Opportunity Assessment By Origin
   14.13 Market Attractiveness Analysis By Origin
   14.14 Latin America Skin Substitutes Market Size Forecast By Application
      14.14.1 Acute Wounds
         14.14.1.1 Burns
         14.14.1.2 Trauma
         14.14.1.3 Others
      14.14.2 Chronic Wound
         14.14.2.1 Diabetic Foot Ulcers
         14.14.2.2 Venous Leg Ulcers
         14.14.2.3 Pressure Ulcer
         14.14.2.4 Skin Cancer (Mohs Surgery)
         14.14.2.5 Others
   14.15 Basis Point Share (BPS) Analysis By Application
   14.16 Absolute $ Opportunity Assessment By Application
   14.17 Market Attractiveness Analysis By Application
   14.18 Latin America Skin Substitutes Market Size Forecast By End-user
      14.18.1 Hospitals
      14.18.2 Ambulatory Surgical Centers
      14.18.3 Clinics
   14.19 Basis Point Share (BPS) Analysis By End-user
   14.20 Absolute $ Opportunity Assessment By End-user
   14.21 Market Attractiveness Analysis By End-user
Chapter 15 Middle East & Africa (MEA) Skin Substitutes Analysis and Forecast
   15.1 Introduction
   15.2 Middle East & Africa (MEA) Skin Substitutes Market Size Forecast by Country
      15.2.1 Saudi Arabia
      15.2.2 South Africa
      15.2.3 UAE
      15.2.4 Rest of Middle East & Africa (MEA)
   15.3 Basis Point Share (BPS) Analysis by Country
   15.4 Absolute $ Opportunity Assessment by Country
   15.5 Market Attractiveness Analysis by Country
   15.6 Middle East & Africa (MEA) Skin Substitutes Market Size Forecast By Type
      15.6.1 Acellular
      15.6.2 Cellular Allogeneic
      15.6.3 Cellular Autologous
      15.6.4 Xenograft
      15.6.5 Others
   15.7 Basis Point Share (BPS) Analysis By Type
   15.8 Absolute $ Opportunity Assessment By Type
   15.9 Market Attractiveness Analysis By Type
   15.10 Middle East & Africa (MEA) Skin Substitutes Market Size Forecast By Origin
      15.10.1 Human Dermis
      15.10.2 Porcine Dermis
      15.10.3 Bovine Dermis
   15.11 Basis Point Share (BPS) Analysis By Origin
   15.12 Absolute $ Opportunity Assessment By Origin
   15.13 Market Attractiveness Analysis By Origin
   15.14 Middle East & Africa (MEA) Skin Substitutes Market Size Forecast By Application
      15.14.1 Acute Wounds
         15.14.1.1 Burns
         15.14.1.2 Trauma
         15.14.1.3 Others
      15.14.2 Chronic Wound
         15.14.2.1 Diabetic Foot Ulcers
         15.14.2.2 Venous Leg Ulcers
         15.14.2.3 Pressure Ulcer
         15.14.2.4 Skin Cancer (Mohs Surgery)
         15.14.2.5 Others
   15.15 Basis Point Share (BPS) Analysis By Application
   15.16 Absolute $ Opportunity Assessment By Application
   15.17 Market Attractiveness Analysis By Application
   15.18 Middle East & Africa (MEA) Skin Substitutes Market Size Forecast By End-user
      15.18.1 Hospitals
      15.18.2 Ambulatory Surgical Centers
      15.18.3 Clinics
   15.19 Basis Point Share (BPS) Analysis By End-user
   15.20 Absolute $ Opportunity Assessment By End-user
   15.21 Market Attractiveness Analysis By End-user
Chapter 16 Competition Landscape
16.1 Skin Substitutes Market: Competitive Dashboard
   16.2 Global Skin Substitutes Market: Market Share Analysis, 2022
   16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      16.3.1 Mölnlycke Health Care AB
      16.3.2 Integra LifeSciences Holdings Corporation
      16.3.3 Organogenesis Holdings Inc
      16.3.4 Tissue Regenix Group plc
    16.3.5 MIMEDX Group, Inc
      16.3.6 Mallinckrodt plc
      16.3.7 HansBiomed Corp.
      16.3.8 Reprise Biomedical Inc.
      16.3.9 Bioventus Inc.
      16.3.10 PolyNovo Limited
      16.3.11 BioHorizons
      16.3.12 Harbor MedTech, Inc.
      16.3.13 Regenity
      16.3.14 Smith+Nephew

Methodology

Purchase Premium Report

Buy Now

Request For Sample

Request For Customization

Enquiry Before Buying

Speak With Analyst

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm

Quick Contact

+1 909 414 1393

sales@growthmarketreports.com

Growth Market Report

Certified By

FAQ Section

Some frequently asked questions about this report!

1. Which is the base year calculated in the Global Skin Substitutes Market report and what is the analysis period?

The base year considered for the Global Skin Substitutes Market report is 2022. The complete analysis period is 2016 to 2031, wherein, 2016 to 2021 are the historic years, and the forecast is provided from 2023 to 2031.

2. Which is the forecast year calculated in the Global Skin Substitutes Market report and what is the analysis period?

The forecast year considered for the Global Skin Substitutes Market report is 2031.

3. What are the factors restraining the growth of the Global Skin Substitutes Market?

Factors such as Regulatory Approvals is expected to hinder the market.

4. What is the impact of COVID-19 on the overall market during the years 2019 -2020?

The COVID-19 pandemic impeded the skin substitutes market due to the decrease in the demand for these products and the disruption of supply chains and manufacturing processes. The skin substitutes market declined during the COVID-19 outbreak primarily due to the postponement or cancellation of elective surgeries, including those involving skin grafts and skin substitutes. This was done to preserve healthcare resources for the treatment of COVID-19 patients and to minimize the risk of infection among patients and healthcare workers.

5. Who are the major players operating in the market?

Major manufacturers include Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Organogenesis Holdings Inc, Tissue Regenix Group plc, MIMEDX Group, Inc, Mallinckrodt plc, HansBiomed Corp., Reprise Biomedical Inc., Bioventus Inc., PolyNovo Limited, BioHorizons, Harbor MedTech, Inc., Regenity, and Smith+Nephew.